Uracyst is well respected world wide. It is being offered in many countries already. From what i gather we should be getting an update soon an these trials from Watson. We should also be hearing from the Kfda as well.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.